Logo

American Heart Association

  14
  0


Final ID: MP342

Aldosterone dysregulation is associated with uncontrolled hypertension: Insights from the real-world BREAKTHROUGH Hypertension Study

Abstract Body (Do not enter title and authors here): Background: Association between serum aldosterone levels and uncontrolled hypertension in a real-world diverse population remains understudied.
Aim: To evaluate the relationship between systolic blood pressure (SBP) and aldosterone dysregulation among patients with essential hypertension.
Methods: Patients with essential hypertension who underwent serum aldosterone measurement between 1/1/2022 and 7/31/2024 were assessed. Patients were divided into cohorts based on SBP ≥130 mmHg (uncontrolled) vs. <130 mmHg and compared according to aldosterone levels, plasma renin activity (PRA), and plasma renin concentration (PRC). Aldosterone dysregulation was defined as aldosterone-to-PRA ratio ≥10 or aldosterone-to-PRC ratio ≥1, and compared with no aldosterone dysregulation group (aldosterone-to-PRA ratio <10 or aldosterone-to-PRC ratio <1), in multivariate logistic regression models adjusted for serum potassium, diabetes, inpatient vs outpatient status, and assay type (immunoassay vs chromatography).
Results: Of the 9129 essential hypertension patients, 7169 (79%) had uncontrolled SBP. Compared to patients with controlled SBP, those with uncontrolled SBP were older, and more like to be males and have diabetes. Patients with controlled SBP showed higher baseline PRA (1.6 vs 1 ng/mL/h; p-value<.0001), PRC (13.3 vs 8.9 pg/mL; p-value<.0001), lower aldosterone-to-PRA ratio (4.3 vs 5.7; p-value<.0001) and aldosterone-to-PRC ratio (0.9 vs 1.2; p-value<.0001), compared with patients with SBP ≥130 mmHg. (Table) Both patients with controlled and uncontrolled SBP experienced aldosterone dysregulation (31.9% vs 41.5% respectively). Patients with aldosterone dysregulation had increased risk of uncontrolled SBP (OR 1.41 [1.26–1. 56]; p<0.0001) compared to those without aldosterone dysregulation. Stratified analyses by age, sex, race, and potassium status showed similar patterns.
Conclusion: In patients with essential hypertension, aldosterone dysregulation was associated with increased risk of uncontrolled hypertension. This association was consistent regardless of demographics and potassium levels.
  • Fioretti, Francesco  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Shaver, Courtney  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Butler, Javed  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Hammonds, Kendall  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Bennett, Monica  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Ettlinger, Jason  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Agiro, Abiy  ( AstraZeneca , Wilmington , Delaware , United States )
  • Luan, Shan  ( Astrazeneca , Wilmington , Delaware , United States )
  • Somerville, Laurence  ( AstraZeneca , Wilmington , Delaware , United States )
  • Khan, Mohammad  ( Baylor Scott and White Health , Plano , Texas , United States )
  • Priest, Elisa  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Author Disclosures:
    Francesco Fioretti: DO NOT have relevant financial relationships | Courtney Shaver: DO NOT have relevant financial relationships | Javed Butler: DO have relevant financial relationships ; Consultant:Abbott :Active (exists now) ; Consultant:Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, NovoNordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, Zoll:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:CVRx:Active (exists now) ; Consultant:CSL Vifor:Active (exists now) ; Consultant:Cardior:Active (exists now) ; Consultant:Cardiac Dimension:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:AskBio:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:American Regent:Active (exists now) ; Consultant:Adaptyx:Active (exists now) | Kendall Hammonds: DO NOT have relevant financial relationships | Monica Bennett: DO NOT have relevant financial relationships | jason ettlinger: No Answer | Abiy Agiro: DO have relevant financial relationships ; Employee:AstraZeneca:Active (exists now) ; Individual Stocks/Stock Options:AstraZeneca:Active (exists now) | Shan Luan: DO have relevant financial relationships ; Employee:AstraZeneca :Active (exists now) | Laurence Somerville: DO NOT have relevant financial relationships | Mohammad Khan: DO have relevant financial relationships ; Consultant:Bayer:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) | Elisa Priest: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Breaking Barriers in Resistant Hypertension

Saturday, 11/08/2025 , 09:15AM - 10:10AM

Moderated Digital Poster Session

More abstracts on this topic:
Angiotensin II Inhibits Renin Secretion Directly By Eliciting Robust Calcium Oscillations In Juxtaglomerular Cells

Yamaguchi Hiroki, Guagliardo Nick, Medrano Silvia, Gomez Ariel, Sequeira Maria Luisa

A Comparison of Synchronized Versus Unsynchronized Mechanical Chest Compressions in a Swine Model

Marill Keith, Menegazzi James, Gumucio Jorge, Salcido David

More abstracts from these authors:
A Review Of The Burden, Management And Outcomes Of Patients With Aldosterone Dysregulation

Luan Shan, Agiro Abiy, Daniel Ian, Mckendrick Jan, Davis Harrison, Huang Joanna, Linganathan Karthik

Aldosterone Dysregulation After Antihypertensive Treatments Among Patients With Hypertension in the United States: Findings From the Breakthrough Aldosterone Real-World Study

Rader Florian, Chertow Glenn, Agiro Abiy, Satija Ambika, Chen Jingyi, Lemus Wirtz Esteban, Brahmbhatt Ashish, Luan Shan, Kang Zoey, Mu Fan

You have to be authorized to contact abstract author. Please, Login
Not Available